Ocular Melanoma - 43 Studies Found
| Recruiting |
: A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma. : Uveal Melanoma : 2015-11-06 : Drug: LXS196 |
| Terminated |
: Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients : Uveal Melanoma : 2009-06-25 : Biological: autologous dendritic cells electroporated with mRNA Autologous mature monocyte-derived dendr |
| Completed |
: Treatment With Intravitreal Avastin for Large Uveal Melanomas : Uveal Melanoma : 2008-01-08 : Drug: AVASTIN a single injection of Avastin at the outpatient clinic. This will be done as follows: the |
| Recruiting |
: Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy : Uveal Melanoma : 2014-08-20 : Drug: Crizotinib An anti-cancer drug acting as an ALK (ana |
| Recruiting |
: Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma : Uveal Melanoma : 2009-12-15 : Drug: CP-675,206 Patients will receive CP-675,206 at 15 mg/kg administered intravenously on day 1 of eve |
| Recruiting |
: Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma : Uveal Melanoma : 2007-04-11 : Procedure: Intraoperative ultrasonography Intraoperative ultrasonography will be used to determine plaqu |
| Recruiting |
: Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma : Uveal Melanoma : 2009-03-30 : Radiation: Hypofractionated linear accelerator radiotherapy 10 fractions of stereotactic linear accelera |
| Completed |
: RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma : Uveal Melanoma : 2010-12-01 : Drug: RAD001 (Everolimus) and Pasireotide (SOM230) LAR Patients will be treated with SOM-230 (pasireotid |
| Active, not recruiting |
: A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma : Uveal Melanoma : 2011-06-14 :
|
| Terminated |
: A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma : Uveal Melanoma : 2013-02-21 :
|